Latest News about ACAD
Recent news which mentions ACAD
   Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
   
  
  
  November 04, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
   
  
  
  November 01, 2022
  From Benzinga
 
   Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
   
  
  
  September 12, 2022
  From Benzinga
 
   U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
   
  September 12, 2022
  Tickers 
   ACAD
  
  
  From Benzinga
 From Benzinga
 
   ACADIA Pharmaceuticals's Return On Capital Employed Insights
   
  August 29, 2022
  Tickers 
   ACAD
  
  
  From Benzinga
 From Benzinga
 
   ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
   
  August 09, 2022
  Tickers 
   ACAD
  
  
  From Benzinga
 From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
   
  
  
  August 08, 2022
  From Benzinga
 
   Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
   
  
  
  August 05, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
   
  
  
  August 05, 2022
  From Benzinga
 From Benzinga
 
   FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions
   
  August 05, 2022
  Tickers 
   ACAD
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   67 Biggest Movers From Yesterday
   
  
  
  June 22, 2022
  From Benzinga
 Tickers 
   ACAD
  
  
  From InvestorPlace
 
   Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
   
  
  
  June 21, 2022
  From Benzinga
 From Benzinga
 
   45 Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  June 21, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
